Professional Marketing briefs

Share this article:
Cegedim Dendrite will deploy a new customer help-desk tool to clients worldwide. Amdocs' Smart Agent Desktop, will automate current processes so that pharma clients receive global reports that help them pinpoint worldwide support issues.

Eisai received a DDMAC warning letter for a Dacogen patient-profile card, a sales aid used when detailing physicians. DDMAC said the card was misleading, because it minimizes risks, overstates efficacy and omits material facts.

Celgene is poised to bring Istodax to market after acquiring the firm that oversaw development, Gloucester Pharmaceuticals. An early 2010 launch is planned for the lymphoma drug.

A recommendation issued by the New Jersey Division of Consumer Affairs calls for a new Board of Medical Examiners rule requiring that 25% of licensed physicians' CME be obtained in evidence-based educational programs or academic detailing.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?